PDS Biotechnology Corp
NASDAQ:PDSB
PDS Biotechnology Corp
NASDAQ:PDSB
Price:
0.5705
USD
-0.09%
Market Closed
Market Cap:
$29.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
PDS Biotechnology Corp
NASDAQ:PDSB
|
US |
|
C
|
Capro Corp
KRX:006380
|
KR |
|
H
|
Hindustan Composites Ltd
NSE:HINDCOMPOS
|
IN |
|
T
|
Tianjin Binhai Teda Logistics Group Corp Ltd
HKEX:8348
|
CN |
|
Z Holdings Corp
TSE:4689
|
JP |
|
Cosco Shipping International (Singapore) Co Ltd
OTC:CSCMY
|
SG |
|
Hotel Holiday Garden
TWSE:2702
|
TW |
|
Cadence Minerals PLC
LSE:KDNC
|
UK |
|
Porr AG
LSE:0J04
|
AT |
|
Knightscope Inc
NASDAQ:KSCP
|
US |
|
OX2 AB (publ)
STO:OX2
|
SE |
Balance Sheet
Balance Sheet Decomposition
PDS Biotechnology Corp
PDS Biotechnology Corp
Balance Sheet Decomposition is not available for
PDS Biotechnology Corp
PDS Biotechnology Corp
Balance Sheet
PDS Biotechnology Corp
PDS Biotechnology Corp
Currency: USD
| Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||
| Cash & Cash Equivalents |
0
|
8
|
14
|
130
|
106
|
88
|
35
|
12
|
29
|
65
|
74
|
57
|
42
|
|
| Cash Equivalents |
0
|
8
|
14
|
130
|
106
|
88
|
35
|
12
|
29
|
65
|
74
|
57
|
42
|
|
| Total Receivables |
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
2
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
3
|
2
|
3
|
|
| Total Current Assets |
0
|
9
|
15
|
131
|
107
|
89
|
36
|
15
|
30
|
67
|
77
|
59
|
45
|
|
| PP&E Net |
0
|
0
|
1
|
3
|
3
|
3
|
0
|
0
|
1
|
0
|
1
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
1
|
3
|
3
|
3
|
0
|
0
|
1
|
0
|
1
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
0
N/A
|
9
+4 250%
|
17
+95%
|
134
+689%
|
111
-17%
|
93
-17%
|
36
-61%
|
15
-60%
|
31
+113%
|
67
+117%
|
77
+15%
|
59
-23%
|
45
-24%
|
|
| Liabilities | ||||||||||||||
| Accounts Payable |
3
|
1
|
2
|
3
|
4
|
4
|
0
|
1
|
1
|
1
|
1
|
7
|
2
|
|
| Accrued Liabilities |
1
|
1
|
2
|
4
|
3
|
5
|
0
|
1
|
2
|
2
|
9
|
2
|
3
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
2
|
0
|
3
|
0
|
0
|
0
|
0
|
0
|
4
|
13
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
6
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
4
|
2
|
4
|
9
|
7
|
13
|
6
|
3
|
3
|
4
|
10
|
14
|
17
|
|
| Long-Term Debt |
0
|
0
|
3
|
3
|
15
|
17
|
0
|
0
|
0
|
0
|
23
|
20
|
9
|
|
| Other Liabilities |
0
|
2
|
2
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
4
N/A
|
3
-3%
|
8
+138%
|
12
+43%
|
22
+86%
|
30
+40%
|
6
-79%
|
3
-56%
|
4
+36%
|
4
+5%
|
33
+725%
|
33
+1%
|
26
-21%
|
|
| Equity | ||||||||||||||
| Common Stock |
4
|
21
|
37
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
8
|
16
|
30
|
62
|
101
|
152
|
193
|
29
|
44
|
61
|
102
|
145
|
182
|
|
| Additional Paid In Capital |
0
|
1
|
2
|
185
|
190
|
214
|
223
|
41
|
71
|
124
|
146
|
171
|
201
|
|
| Total Equity |
3
N/A
|
5
N/A
|
9
+70%
|
123
+1 261%
|
89
-27%
|
62
-30%
|
30
-52%
|
12
-61%
|
27
+132%
|
63
+133%
|
44
-30%
|
26
-41%
|
19
-27%
|
|
| Total Liabilities & Equity |
0
N/A
|
9
+4 250%
|
17
+95%
|
134
+689%
|
111
-17%
|
93
-17%
|
36
-61%
|
15
-60%
|
31
+113%
|
67
+117%
|
77
+15%
|
59
-23%
|
45
-24%
|
|
| Shares Outstanding | ||||||||||||||
| Common Shares Outstanding |
1
|
1
|
1
|
1
|
1
|
2
|
2
|
5
|
22
|
28
|
30
|
33
|
38
|
|
Switch to:
Switch to:
See Also
Discover More
